New data indicates that retatrutide, a novel medication, might represent a major improvement in size reduction . This treatment combines the actions of a GLP-1 analog and a GIP analog, potentially offering a greater impact than current solutions. Patient trials have revealed promising findings , including significant reductions in size and gains i